Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT05328921
  4. Details
NCT05328921 Clinical Trial

Effects of Systemic Drugs on Intraocular Pressure

Hypertension Clinical Trial

Official title:
Effects of Two Systemic Drugs on Intraocular Pressure in Narrow Angle Glaucoma

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05328921
Other study ID # Rc 9-22
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 7, 2022
Est. completion date September 30, 2022

Study information
Verified date April 2022
Source Benha University
Contact Ahmed Abdelshafy, MD
Phone 01222328766
Email ahmad4lg@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To assess intraocular pressure changes among glaucoma patients on systemic antihypertensive and antihistaminic drugs.

Description:

Changes in intraocular pressure in glaucomatous patients with narrow angle may elicit attacks of angle closure glaucoma. In this study we aim to assess changes in intraocular pressure (IOP) among glaucomatous patients on systemic antihypertensive and antihistaminic drugs.

Recruitment information / eligibility
Status Recruiting
Enrollment 200
Est. completion date September 30, 2022
Est. primary completion date September 15, 2022
Accepts healthy volunteers
Gender All
Age group 35 Years to 70 Years
Eligibility Inclusion Criteria: - patients with narrow angle glaucoma on systemic antihypertensive and/or antihistaminic drugs. Exclusion Criteria: - open angle glaucoma patients confirmed by gonioscopy examination. - Cases with dense corneal opacity or iris trauma that may affects gonioscopy examination. - cases with secondary glaucoma.

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Antihypertensive Agents
Patients with narrow angle glaucoma and on systemic antihypertensive drugs.
• Antihistaminics
Patients with narrow angle glaucoma and on systemic antihistaminic drugs.

Locations
Country Name City State
Egypt Ahmed Abdelshafy Banha QA

Sponsors (1)
Lead Sponsor Collaborator
Benha University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Changes in intraocular pressure (IOP) measured by applanation tonometry Changes in IOP measured by millimeter mercury (mmHg) Immediately after visual acuity assessment for each eye after topical anesthetic eye drops and again on one and three months visit
Secondary Changes in pupil diameter Size of pupil measured in millimeters (mm) 7sing autorefractometer Immediately after slit lamp examination and again on one and three months visit
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A